Skip to content

IVPOWER - effectiveness and efficiency of contracts in integrative care from patients suffering serious mental illnesses in real surroundings with particular attention to improvement of empowerment and quality of life

IVPOWER - effectiveness and efficiency of contracts in integrative care from patients suffering serious mental illnesses in real surroundings with particular attention to improvement of empowerment and quality of life - IVPOWER

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00005111
Enrollment
750
Registered
2013-07-26
Start date
2013-08-23
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F20-F29 F30-F39 F40-F48 F60-F69

Interventions

Group 1: The integrated care-group consists of 250 patients (50 patients per region) with schizophrenic (F2 ICD-10), affective (F3 ICD-10) disorders or other serious mental illnesses, who enroll in th

Sponsors

Universität Ulm Klinik für Psychiatrie und Psychotherapie II Sektion: Gesundheitsökonomie und Versorgungsforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The integrated care group consists of 250 patients (50 patients per region) with schizophrenic (F2 ICD-10), affective (F3 ICD-10) disorders or other serious mental illnesses, who enroll in a program for integrated care according to the NWpG model within 6 months after start of study. /// The control group consists of 250 patients (50 patients per region) with schizophrenic (F2 ICD-10), affective (F3 ICD-10) disorders or other serious mental illnesses, who meet the criteria for enrollment in the program for integrated care according to the NWpG model but who haven’t enrolled so far and who are not willing to enroll in an integrated care program according to the NWpG during course of the study. /// Relatives and close persons of reference of in study included patients, who are willing to take part at study.

Exclusion criteria

Exclusion criteria: primary diagnosis of ICD-10 groups F0 – F1; existence of a care level

Design outcomes

Primary

MeasureTime frame
EPAS: change in empowerment total score over 18 months; measuring points: 0 month / 6 months / 12 months / 18 months

Secondary

MeasureTime frame
Interrogation of patients: measuring points: 0 month / 6 months / 12 months / 18 months Reduction in psychosocial and clinical impairment using HoNos Improvement of subjective quality of life using WHO-QoL Reduction of unmet needs for psychiatric and psychosocial services using CAN-EU Increase in satisfaction with psychiatric treatment using ZuF8 Reduction of utilization of stationary and simultaneous increase in utilization of ambulatory medical and psychosocial services using CSSRI Reduction of direct and indirect healthcare costs using CSSRI Reduction of costs of recovering a “healthy” year of life (QALY) using EQ-5D /// Interrogation of relatives and persons of reference: measuring points: 0 month / 6 months / 12 months / 18 months Perception of burden related to support of patient suffering serious mental illness using IEQ Subjective quality of life using WHO-QoL-BREF Satisfaction with psychiatric treatment using ZuF8

Countries

Germany

Contacts

Public ContactAnnabel Stierlin

Universität Ulm Klinik für Psychiatrie und Psychotherapie II Sektion: Gesundheitsökonomie und Versorgungsforschung

annabel-sandra.stierlin@bkh-guenzburg.de++49 (0)8221 9629202

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 9, 2026